Harpagoside | CAS 19210-12-9

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Product Overview

Product Name	Harpagoside
CAS	19210-12-9
Formula	C24H30O11
MW	494.49
Appearance	Light yellow to yellow powder
Storage condition	4°C, protect from light

Product details

Anti-inflammatory and anti-diabetic compound. Suppresses LPS-induced inducible nitric oxide synthase (iNOS; NOS II) and cyclooxygenase-2 (COX-2) expression through inhibition of NF-κB activation.

Related literature

Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay.

PMID: 20812280 DOI: 10.1002/ptr.3124

Sorry, no related items

History

Anti-CD33 (gemtuzumab ozogamicin biosimilar) mAb

220578-59-6 95+%

CLA1049

Anti-EPHA3 (ifabotuzumab biosimilar) mAb

Enokizumab (Anti-IL-9)

909875-08-7 95+%

CLA1295

Patritumab (Anti-ERBB3 / HER3)

Elacridar (Synonyms: GF120918; GW0918; GG918; GW120918)

143664-11-3 98+%

哈巴俄苷

Chemical safety data sheet(MSDS)